Today, he shares why he believes that collaborating with patients is necessary to the industry right now.
I’m a Clinician, but I think I’m even more a product person. I’ve been in the software development world for a while. I still do a little bit of moonlighting, but really most of my thinking is on building tools. If I put my product hat on and think about the clinical trial as a product, part of the sale of that product is to get the trial to the patient and get the patient to enroll in the trial.
It’s interesting to take that perspective because what we have is organizations and researchers in academia or industry who put together this product. A bunch of experts, a ton of resources topping in the many millions of dollars invested to put together this product. It gets built, it gets shrink-wrapped and it gets distributed to all the trial sites. Only then, once it is on the shelves, if you will, that’s the first time that the consumer of this product—the patients that may enroll—is exposed to the product. If you use that analogy in any other industry, most people would say that it would be crazy not to get any feedback in the course of designing the trial. This violates every rule of user-centric design.
So, I think that one way of putting it is that the drug development space is ready to think more about some of those principles of user-centric design, in particular in the clinical trial space where there are so many operational aspects of the trial that can make the experience worse or better. To some extent, it is as simple as applying the principles of user-centric design to trial development.
For Roni's complete interview from Inside Outsourcing, including his views on including patients as partners in the clinical process, their care givers, and how sponsors and clinical researchers can overcome that obstacles that may arise, download the full podcast here.
Roni Zeiger will be presenting the keynote speech Patient Centricity and Data Converge: How the Next Generation of Social Medicine Impacts Clinical Trials at Partnerships in Clinical Trials on Tuesday, April 1. To find out more about his presentation and the rest of the event, download the agenda. If you'd like to join us, as a reader of this blog, when you register to join us and mention code XP1900BLOG, you'll save $100 off the current rate!